University of Florida researchers developed an experimental mRNA vaccine that triggered a rapid immune response against glioblastoma in a tiny initial trial of four patients, but the claim that it safely erased brain tumors without chemotherapy or radiation overstates preliminary findings and misrepresents the scope of the study.
Scientists at the University of Florida have created an mRNA cancer vaccine that erased brain tumors in early human trials without chemotherapy or radiation.

Dr. Elias Sayour – RNA-NANOPARTICLE VACCINES FOR PEDIATRIC HIGH-GRADE GLIOMA | CureSearch
Source: curesearch.org
Key Evidence
A first-in-human clinical trial evaluated four adult patients with glioblastoma to test the safety and immune activation of a UF-developed mRNA vaccine.
The treatment successfully triggered a rapid and robust inflammatory immune response within forty-eight hours of administration.
Available clinical data and peer-reviewed studies do not establish that the vaccine erased brain tumors or eliminated the need for standard therapies.
What the Evidence Shows
Researchers at the University of Florida developed an experimental RNA nanoparticle vaccine designed to reprogram the immune system against glioblastoma, which is an aggressive form of brain cancer. Initial findings from a first-in-human clinical trial involving four adult patients demonstrated that the treatment could rapidly provoke a robust inflammatory immune response within forty-eight hours of administration.healio.comhealio.commRNA vaccine reprograms immune system to attack glioblastomaWhat the Study Actually Did and Found First-in-Human Phase 1 Trial Size: The initial human clinical trial evaluated only four adult patients with glioblastoma (a notoriously aggressive and treatment-resistant brain cancer) The Immune...
ufhealth.orgufhealth.orgNew mRNA cancer vaccine triggers fierce immune response to fight malignant brain...Elias Sayour, a pediatric oncologist and researcher at the University of Florida (UF) Health Cancer Center and the McKnight Brain Institute According to the study, this structural design provokes a much more profound "danger signal" to...
However, the claim that the vaccine completely erased brain tumors in these early trials without standard interventions misstates the nature and current goals of the research. Peer-reviewed data published in the journal Cell showed that the trial was primarily designed to evaluate safety and immune activation rather than to establish a definitive cure or replace conventional therapies entirely.trial.medpath.comtrial.medpath.comUniversity of Florida Mrna Vaccine Shows Rapid Immune Response Against...The Core Findings (Published in Cell) Initial Human Trial Scope: The initial first-in-human clinical trial evaluated four adult patients suffering from glioblastoma, the most aggressive and lethal form of primary brain tumor Rapid Immune...+1 more
While the initial data supported expanding the work into larger clinical trials and pediatric evaluations, the available evidence does not support the assertion that the vaccine has successfully and universally eradicated brain tumors in human patients without other treatments.experts.ufl.eduexperts.ufl.eduExperts ReportTrial Expansion: Based on the successful early safety and immune-activation readouts, the research team expanded the work into larger clinical trials, including planned Phase 1 pediatric brain cancer trials and broader evaluations to test...
cancer.ufl.educancer.ufl.eduUF-developed mRNA vaccine triggers fierce immune response to fight malignant...Based on official press releases, institutional reports, peer-reviewed data, and summaries by agencies like the National Cancer Institute (NCI), the claim is exaggerated and inaccurate in several critical details, though it is based on a...
Verified Sources7
mRNA vaccine reprograms immune system to attack glioblastoma
New mRNA cancer vaccine triggers fierce immune response to fight malignant brain...
Revision history
- Version 2October 12, 2026
The newly completed fact check evaluated the claim more rigorously against peer-reviewed data and determined that while an early trial showed immune activation in four patients, the assertion that the vaccine erased brain tumors without standard interventions overstates preliminary findings, shifting the verdict from Mostly True to Mostly False.
Mostly True → Mostly False - Version 1August 19, 2025
Initial published version
Mostly True